CA Stock MarketDetailed Quotes

HBP Helix BioPharma Corp

Watchlist
  • 0.910
  • -0.070-7.14%
15min DelayMarket Closed Mar 3 16:00 ET
48.25MMarket Cap-0.87P/E (TTM)

About Helix BioPharma Corp Company

Helix BioPharma Corp is a clinical-stage biopharmaceutical company. It is focused on cancer drug development. The company develops therapies in the field of immuno-oncology based on its proprietary technology mainly in the areas of cancer prevention and treatment. Its pipeline candidate is L-DOS47 for Tumor Defence Breaker is in clinical trials for pancreatic cancer.

Company Profile

SymbolHBP
Company NameHelix BioPharma Corp
Founded1995
MarketTSE
Employees7
Fiscal Year Ends07-31
Address40 Temperance Street Suite 2700, Bay Adelaide Centre - North Tower
CityToronto
CountryCAN
Zip CodeM5H0B4
Phone+1 604 684-2181

Company Executives

  • Name
  • Position
  • Salary
  • Jacek Antas
  • Corporate Secretary, Chairman of the Board and Chief Executive Officer
  • --
  • James Murphy
  • Chief Financial Officer
  • --
  • Jerzy Leszczynski
  • Independent Director
  • --
  • Janusz Grabski
  • Independent Director
  • --
  • Malgorzata Laube
  • Independent Director
  • --
Trending Stocks
Big Five Big Five

The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.